Evidence map›Paper›PMID 36131274›Full record

ArticleBMC medical informatics and decision making2022

Correlating drug prescriptions with prognosis in severe COVID-19: first step towards resource management.

Anna S Levin, Maristela P Freire, Maura Salaroli de Oliveira, Ana Catharina S Nastri, Leila S Harima, Lauro Vieira Perdigão-Neto, Marcello M Magri, Gabriel Fialkovitz, Pedro H M F Figueiredo, Rinaldo Focaccia Siciliano and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical informatics and decision making, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Anna S LevinDepartment of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. gcih.adm@hc.fm.usp.br.
Maristela P FreireDepartment of Infection Control, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.
Maura Salaroli de OliveiraDepartment of Infection Control, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.
Ana Catharina S NastriDivision of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Leila S HarimaClinical Director's Office, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Lauro Vieira Perdigão-NetoDepartment of Infection Control, Hospital das Clínicas, Universidade de São Paulo, São Paulo, Brazil.
Marcello M MagriDivision of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Gabriel FialkovitzDivision of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Pedro H M F FigueiredoNúcleo de Vigilância Epidemiológica, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Rinaldo Focaccia SicilianoDivision of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Ester C SabinoDepartment of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Danilo P N CarlottiComputer Science Department, Institute of Mathematics and Statistics, Universidade de São Paulo, São Paulo, Brazil.
Davi Silva RodriguesLaboratory of Computer Applications for Health Care; School of Arts, Sciences and Humanities, Universidade de São Paulo, São Paulo, Brazil.
Fátima L S NunesLaboratory of Computer Applications for Health Care; School of Arts, Sciences and Humanities, Universidade de São Paulo, São Paulo, Brazil.
João Eduardo FerreiraComputer Science Department, Institute of Mathematics and Statistics, Universidade de São Paulo, São Paulo, Brazil.
HCFMUSP COVID-19 Study Group
Universidade de São Paulo · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOptimal COVID-19 management is still undefined. In this complicated scenario, the construction of a computational model capable of extracting information from electronic medical records, correlating signs, symptoms and medical prescriptions, could improve patient management/prognosis.

methodsThe aim of this study is to investigate the correlation between drug prescriptions and outcome in patients with COVID-19. We extracted data from 3674 medical records of hospitalized patients: drug prescriptions, outcome, and demographics. The outcome evaluated was hospital outcome. We applied correlation analysis using a Logistic Regression algorithm for machine learning with Lasso and Matthews correlation coefficient.

resultsWe found correlations between drugs and patient outcomes (death/discharged alive). Anticoagulants, used very frequently during all phases of the disease, were associated with good prognosis only after the first week of symptoms. Antibiotics very frequently prescribed, especially early, were not correlated with outcome, suggesting that bacterial infections may not be important in determining prognosis. There were no differences between age groups.

conclusionsIn conclusion, we achieved an important result in the area of Artificial Intelligence, as we were able to establish a correlation between concrete variables in a real and extremely complex environment of clinical data from COVID-19. Our results are an initial and promising contribution in decision-making and real-time environments to support resource management and forecasting prognosis of patients with COVID-19.

Indexed as

COVID-19 Drug TreatmentAnti-Bacterial AgentsAnticoagulantsArtificial IntelligenceDrug PrescriptionsHospitalizationHumansPrognosisRetrospective StudiesAnti-Bacterial AgentsAnticoagulantsHospitalizationPrognosisSevere COVID-19Treatment

Identifiers

PMID36131274
PMCPMC9490728
OpenAlexW4296709906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.